Laboratory for HIV and Opportunistic Infections Diagnosis
Elena GASICH, Docent, Doctor of Biol. Sci.
Laboratory for HIV and Opportunistic Infections Diagnosis as a independent structure was established on September 01, 1998 due to the fact that the problem of HIV infection as well as parenteral hepatitis B and C became more and more urgent and required the introduction of new more efficient and effective methods for controlling pathogens.
According to the order of the Ministry of Health of the Republic of Belarus of 14.05.2012 No. 546, at the base of the laboratory there is a "Republican reference laboratory for genodiagnosis of HIV infection, parenteral hepatitis B and C for determining subtypes and resistance to antiviral drugs for HIV, hepatitis B and C therapy".
Today we are the mail laboratory for HIV, HBV HCV etc. diagnosis fully equipped for IB, ELISA, PCR, Sequencing analyses with qualified personal.
Our main area of research:
- Molecular epidemiology of HIV, HBV HCV and another viruses on the territory of Belarus
We perform analyses for clinical reporting:
- HIV IB, ELISA test, viral load, subtyping and drug resistance analysis;
- HCV ELISA test, viral load, subtyping, drug resistance to DAADs, IL28 gene polymorphism;
- HBV ELISA test, viral load, subtyping, drug resistance;
- PCR analysis of various Sexually transmitted infections (STIs).
We have collections:
- Serum/plasma collection from HIV-, HBV- and HCV-infected patients;
- HIV collection.
- V. Eremin, E. Gasich, S. Sasinovich, et al. Investigation of HIV outbreaks among people who use psychotropic injection drugs using methods of molecular epidemiology, VICH-infekcija i immunosupressii. 8/4 (2016) P.66-74 (in Russian).
- E. Gasich, V. Eremin, Molecular epidemiology of hepatitis B virus, isolated in Belarus, VICH-infekcija i immunosupressii. 5/4 (2016) P.43-54 (in Russian).
- S. Sasinovich, V. Eremin, E. Gasich. HIV-1 recombinant forms revealed in Belarus: diversity, origin and domestic spread, Zdravoohranenie. 7 (2016) 74-80. (in Russian)
- V. Eremin, E. Gasich, S. Sasinovich, et al. HBV S and P gene mutations, Journal of Clinical Virology. 69 (2015) 231. doi:10.1016/j.jcv.2015.06.031.
- S. Sasinovich, V. Eremin, E. Gasich, M. Thomson, Complete genome sequence of new unique recombinant HIV type 1 isolated from a child born to an HIV-infected mother, BMC Infectious Diseases. 14 (2014) P62. doi:10.1186/1471-2334-14-S2-P62.
- E. Gasich, V. Eremin, S. Sasinovich. Genetic diversity of hepatitis C virus in children with cancer, Zdravoohranenie. 10 (2014) 59-64. (in Russian)
- V. Eremin, E. Gasich, S. Sasinovich. HIV drug resistance mutations in HIV-infected individuals on and without HAART, Zdravoohranenie. 10 (2014) 24вЂ“30. (in Russian)
- V. Eremin, E. Gasich, S. Sasinovich, O. Suetnov, I. Kucherov, HIV Drug Resistance at Patients on HAART and Transmitted HIV Drug Resistance (tHIVDR) in Treatment Naive Patients in Belarus, J AIDS Clin Res. 4 (2013). doi:10.4172/2155-6113.1000258.
- V. Eremin, E. Gasich, S. Sasinovich, A new unique recombinant HIV-1 revealed in Belarus, Retrovirology. 9 (2012) P32. doi:10.1186/1742-4690-9-S1-P32.
- E. Gasich, V. Eremin, S. Sasinovich, M. Tulinova, HBV and HCV genotypes distribution on the territory of Belarus, Retrovirology. 9 (2012) P57. doi:10.1186/1742-4690-9-S1-P57.
- V. Eremin, E. Gasich, S. Sasinovich, A new unique recombinant HIV type 1 isolated from a child born to an HIV-infected mother, AIDS Research and Human Retroviruses. 27 (2011) 1323вЂ“1326. doi:10.1089/AID.2011.0112.